Sensyne Health
Also: Vocalis Health and Mayo Clinic seek new pulmonary hypertension biomarkers; Sensyne Health and Microsoft's strategic partnership focuses on clinical AI co-development.
The firm also announced a deal with a Fortune 200 company to launch gestational diabetes product in the US.
The German firm will provide pharmaceutical insight in a consortium which aims to accelerate discovery and development of new medicines using clinical AI.
Oxford-based Sensyne Health announces partnership with EY.